HealthQuill USFDA
The Food and Drug Administration has cleared X4 Pharmaceutical’s drug to treat a rare genetic disease that occurs in one in five million births.
Drugs Health Pharma

X4 Pharmaceutical’s drug to fight WHIM syndrome gets green light

HQ Team April 30, 2024: The Food and Drug Administration has cleared X4 Pharmaceutical’s drug to treat a rare genetic disease that occurs.

Read More
The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond the chemotherapy stage.
Drugs Health Pharma

Pfizer gets full US regulatory approval for cervical cancer drug

HQ Team April 30, 2024: The US health regulator has approved Pfizer’s drug to treat cervical cancer patients whose disease has progressed beyond.

Read More
The US health regulator has approved a drug of Utility Therapeutics to treat adult women, 18 years or older, with “uncomplicated” urinary tract infections.
Drugs Health Pharma

Utility Therapeutics gets FDA nod for drug to fight urinary tract infections

HQ Team April 25, 2024: The US health regulator has approved a drug of Utility Therapeutics to treat adult women, 18 years or.

Read More
Almost a year after rejecting approval for ImmunityBio’s combination therapy to treat a type of bladder cancer the USFDA has given the green light to the company’s Anktiva treatment.
Drugs Health Pharma

USFDA grants approval for ImmunityBio’s bladder cancer drug

HQ Team April 23, 2024: Almost a year after rejecting approval for ImmunityBio’s combination therapy to treat a type of bladder cancer the.

Read More
Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the marketing authorisations for its amyotrophic lateral sclerosis (ALS) therapy after the drug failed in a last-stage trial.
Drugs Health Pharma

Amylyx Pharma pulls out ALS therapy drug from US, Canada

HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the.

Read More
The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and skin infections in adults and community-acquired bacterial pneumonia in patients three months to 18 years, and adults. 
Drugs Health Pharma

Swiss-based Basilea Pharmaceutical’s antimicrobial drug gets FDA nod 

HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and.

Read More
US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering the feasibility of processing pharmaceuticals in microgravity.
Drugs Health Pharma

US-based Varda Space crystallises HIV drug in microgravity

 HQ Team March 31, 2024: US-based Varda Space Industries’ spacecraft in orbit crystallised a metastable form of a drug for HIV/AIDS — furthering.

Read More
The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to treat pulmonary arterial hypertension.
Drugs Health Pharma

US regulator clears Merck’s lung therapy after ‘significant’ results

 HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to.

Read More
The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to “unreasonable and substantial risk” of illness or injury.
Drugs Medical Pharma

FDA attempts a second time to ban electrical stimulation devices

HQ Team March 26, 2024: The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to “unreasonable and.

Read More
The US Food and Drug Administration has cleared Orchard Therapeutics’s gene therapy to treat a disease affecting the brain and nervous system in children — the regulator’s first ever for the disorder.
Drugs Health Pharma

FDA green lights first-ever therapy for rare genetic disease in kids

HQ Team March 19, 2023: The US Food and Drug Administration has cleared Orchard Therapeutics’s gene therapy to treat a disease affecting the.

Read More